Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? (Q80167347)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

V Michael Holers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Rheumatology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

400-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

Evolving concepts of rheumatoid arthritis

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Citrullination: a small change for a protein with great consequences for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0247

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932728%20AND%20SRC:MED&resulttype=core&format=json